Artblood
Artblood is a cell-based artificial blood production company.
Artblood is active in the artificial intelligence (ai), biotechnology space based in Asia-Pacific (APAC), founded in 2022.
Its activity falls under artificial intelligence (ai), biotechnology; the profile below is assembled from public directory data.
The business is associated with Asia-Pacific (APAC).
Directory data places it at the Series_A stage.
Public records show total funding of about $6.5B.
| Sector | Artificial Intelligence (AI), Biotechnology |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2022 |
| Stage | series_a |
| Total funding | $6,500,000,000 |
Website: www.artblood.kr
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account